Peters William J sold 4,139 shares of Amphastar Pharmaceuticals, Inc. at $25.00 for −$103k on Sep 21, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
CFO, EVP & TREASURER
CFO, EVP & TREASURER
Filed Sep 23, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$103,475Shares × reported price
Shares traded
4,139Common Stock
Price per share
$25.00Reported price. Read footnotes for ranges.
% of reported position traded
2.39%This security and ownership context
Holdings after
168,707Direct
Trade date
Sep 21, 2026Sell
Filed
Sep 23, 2026, 6:02 PM ET2-day reporting delay
Accession
0001263136-26-000014Code S · Transaction 228568
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 172,846 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

AMPH price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
AMPH · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago −4.2%1d ago −5.4%
Returns since7d +3.4%30d +0.7%90d180d1y

Footnotes in full

F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2026.